SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-22-115067
Filing Date
2022-04-22
Accepted
2022-04-22 16:01:01
Documents
7
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A d342375dpre14a.htm PRE 14A 732069
2 GRAPHIC g342375g19c19.jpg GRAPHIC 45982
3 GRAPHIC g342375g19c20.jpg GRAPHIC 48144
4 GRAPHIC g342375g19c21.jpg GRAPHIC 51616
5 GRAPHIC g342375g28c29.jpg GRAPHIC 31609
6 GRAPHIC g342375page066.jpg GRAPHIC 114158
7 GRAPHIC g342375page067.jpg GRAPHIC 104475
  Complete submission text file 0001193125-22-115067.txt   1275417
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35890 | Film No.: 22845426
SIC: 2834 Pharmaceutical Preparations